Remove 2025 Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

STAT+: Pharmalittle: We’re reading about senators probing telehealth, Boston’s slumping biotech hub and more

STAT

senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceutical manufacturers Pfizer and Eli Lilly, interrogating their financial relationships , STAT tells us. Telehealth companies that prescribe a range of medications have not been held to the same standards. 

article thumbnail

Key Trends Reshaping Pharmaceutical Market Access in 2025

Pharma Leaders

In a rapidly transforming pharmaceutical landscape, securing market access remains paramount. Looking ahead in 2025, several pivotal trends are set to redefine strategies for manufacturers and industry stakeholders. Source: Pharm Exec , January 31, 2025

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical Technology Excellence Awards 2025: i3 Membrane

Pharmaceutical Technology

This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. This flexibility is particularly beneficial for pharmaceutical manufacturers looking to upgrade their research and discovery processes without overhauling their entire systems.

article thumbnail

Kashmik Formulation plans 50 per cent production capacity expansion and targets ₹100 crore revenue in FY26

Express Pharma

Kashmik Formulation, a pharma manufacturing firm based in Ahmedabad, has announced plans to expand its production capacity, increase automation, and enhance its international footprint. To support this, the company is investing approximately ₹20 crore in infrastructure development, which is already underway.

article thumbnail

Asahi Kasei establishes life science division to streamline bioprocess operations for pharma sector

Express Pharma

To address growing demand from the pharmaceutical industry, Asahi Kasei has launched a new division, Asahi Kasei Life Science, effective from 1 April 2025. The new structure is designed to unify its bioprocess businesses and streamline services offered to pharmaceutical partners across drug development and manufacturing.

article thumbnail

EU Urban Wastewater Treatment Directive may compromise EU medicine availability

European Pharmaceutical Review

Based on the new cost estimates, pharmaceutical manufacturers in Finland alone will be required to fund 280816 million of these expenses, The directive , enforced on 1 January 2025, imposes an extended manufacturer responsibility on the removal of micro-pollutants from wastewaters.

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.